Aclaris Therapeutics Inc (ACRS): Gewinn- und Verlustrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 8.219 | 7.826 | 18.720 | 31.249 | 29.752 | 6.761 | 6.482 | 4.227 | 10.091 | 1.683 |
Herstellungskosten | 361 | 2.091 | 2.792 | 18.081 | 11.960 | 4.713 | 5.133 | 4.055 | 6.850 | 1.207 |
Bruttoergebnis | 7.858 | 5.735 | 15.928 | 13.168 | 17.792 | 2.048 | 1.349 | 172 | 3.241 | 476 |
▸ Brutto-Marge | 95,61% | 73,28% | 85,09% | 42,14% | 59,8% | 30,29% | 20,81% | 4,07% | 32,12% | 28,28% |
Betriebliche Aufwendungen | 94.171 | 82.110 | 157.860 | 110.525 | 107.646 | 91.771 | 52.261 | 111.230 | 138.655 | 72.899 |
Operativer Gewinn/Verlust | -86.313 | -76.375 | -141.932 | -97.357 | -89.854 | -89.723 | -50.912 | -111.058 | -135.414 | -72.423 |
▸ Operative Marge | -1.050,16% | -975,91% | -758,18% | -311,55% | -302,01% | -1.327,07% | -785,44% | -2.627,35% | -1.341,93% | -4.303,21% |
Zinsen (Netto) | 6.728 | 7.637 | 7.953 | - | -4.700 | -23.416 | -1.039 | - | - | - |
▸ Zinsausgaben | - | - | - | - | 4.700 | 23.416 | 1.039 | - | - | - |
▸ Zinseinnahmen | 6.728 | 7.637 | 7.953 | - | - | - | - | - | - | - |
Andere Ausgaben | -3.847 | -3.815 | -1.914 | -8.509 | -7.646 | -22.274 | -615 | 2.484 | -2.676 | -2.070 |
Gewinn vor Steuern | -75.738 | -64.923 | -132.065 | -88.848 | -86.908 | -90.865 | -51.336 | -113.542 | -132.738 | -70.353 |
Steueraufwand | - | - | - | -367 | 1.754 | 23.416 | -182 | 29.308 | 2.676 | -1.830 |
Minderheitenanteil | - | - | - | - | -1.754 | -23.416 | -139 | 18.504 | -2.676 | - |
Nettogewinn/-verlust | -75.738 | -64.923 | -132.065 | -88.481 | -86.908 | -90.865 | -51.015 | -161.354 | -132.738 | -68.523 |
▸ Netto-Marge | -921,5% | -829,58% | -705,48% | -283,15% | -292,11% | -1.343,96% | -787,03% | -3.817,22% | -1.315,41% | -4.071,48% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.